Metraipolis › archive › dc_3f2d52d2459f
Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41127589
- DOI
- 10.3389/fpubh.2025.1658760
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:16:55.129Z
- SHA-256 of the archived text
2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527- Stable URL of this page
https://metraipolis.com/documento/dc_3f2d52d2459f
How to cite
Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589 — Europe PMC (en), https://europepmc.org/article/MED/41127589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f2d52d2459f (Metraipolis archive dc_3f2d52d2459f, sha256 2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527)
BibTeX
@misc{dc3f2d52d2459f,
title = {Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review — Europe PMC PMID:41127589},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41127589},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f2d52d2459f; sha256 2b2d80a8abe0fccaf9ce3973ad44bdb439175ea61f56028efac406f3fbc29527},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41127589. Agents can read the archived copy with the MCP tool read_document.